Potash Company Lands Major Order

Streetwise Reports - Exclusive Articles |

Source: Streetwise Reports   06/26/2018

Potash producer Verde AgriTech Plc (NPK:TSX; AMHPF:OTCQB) received from an existing customer an order that is 15 times larger than its previous one. This time, the Brazilian agricultural producer ordered 3,250 tons of Super Greensand versus 198 tons in 2017, according to a news release. The product's sale price this time around was higher than that indicated in Verde's November 2017 prefeasibility study (PFS), due to higher potash prices.

Verde's president and CEO Cristiano Veloso noted that receiving a second, much larger order from the client was gratifying. He added that "this growth in demand for Super Greensand is what we expect from the market, both from famers that run a trial over a harvest period and from farmers that learn about prior success from neighboring farms."

Verde had begun working with this customer back in 2014 to help meet the needs for potash across the plantations and kept the buyer updated about the various field tests done on Super Greensand.

As for progress on its Cerrado Verde project in Brazil, Verde is constructing a production plant from which it "intends to produce solutions for crop nutrition, crop protection, soil improvement and increased sustainability," the release described. The plant is expected to be operating in H2/18.

There, the company should ultimately be able to process about 300 thousand tons per year (300 Kt/year), which equals a rate of roughly 45 tons per hour, at a cost of $500,000. The project PFS outlined that production would ramp up in three phases: 600 Kt/year to 5 million tons per year (5 Mt/year) to 25 Mt/year.

The PFS also showed for Cerrado Verde a net present value of $1.98 billion and an internal rate of return of 290%.

Read what other experts are saying about:

Want to read more Energy Report articles like this? Sign up for our free e-newsletter, and you'll learn when new articles have been published. To see a list of recent articles and interviews with industry analysts and commentators, visit our Streetwise Interviews page.



Disclosure:
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: Verde AgriTech. Click here for important disclosures about sponsor fees. As of the date of this article, an affiliate of Streetwise Reports has a consulting relationship with Verde AgriTech. Please click here for more information.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article, until one week after the publication of the interview or article. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Verde AgriTech, a company mentioned in this article.

( Companies Mentioned: NPK:TSX; AMHPF:OTCQB, )

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.